JAN 20, 2021 7:49 PM PST

Designer Cytokine: Potential Therapeutic Approach for Paralysis

WRITTEN BY: Nouran Amin

Paralysis due to spinal cord damage remains an irreparable condition. However, a new therapeutic approach may bring renewed hope for paralysis patients. The approach involves a ‘designer’ cytokine that stimulates the nerve cells to regenerate. The cytokine is called hyper-interleukin-6.

"This is a so-called designer cytokine, which means it doesn't occur like this in nature and has to be produced using genetic engineering," explains Dietmar Fischer.

"Thus, gene therapy treatment of only a few nerve cells stimulated the axonal regeneration of various nerve cells in the brain and several motor tracts in the spinal cord simultaneously," points out Dietmar Fischer. "Ultimately, this enabled the previously paralyzed animals that received this treatment to start walking after two to three weeks. This came as a great surprise to us at the beginning, as it had never been shown to be possible before after full paraplegia."

Learn more about spinal trauma:

"This aspect would be particularly relevant for application in humans," stresses Fischer. "We are now breaking new scientific ground. These further experiments will show, among other things, whether it will be possible to transfer these new approaches to humans in the future."

Source: Science Daily  

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 09, 2020
Technology
AI Helps Drug Combination Therapy in Cancer
DEC 09, 2020
AI Helps Drug Combination Therapy in Cancer
Healthcare providers opt to multiple of therapies for cancer patients—often containing combo drugs. Research has s ...
DEC 11, 2020
Drug Discovery & Development
Could Tomatoes Be Therapy for Parkinson?
DEC 11, 2020
Could Tomatoes Be Therapy for Parkinson?
Could tomatoes be the next Parkinson’s drug? Researchers have introduced novel use of tomatoes for therapy. Scient ...
DEC 24, 2020
Drug Discovery & Development
New Gene Therapy Targets Deafness
DEC 24, 2020
New Gene Therapy Targets Deafness
New gene therapy study addresses treatment methods for deafness. "In this study we focused on genetic deafness caus ...
DEC 28, 2020
Immunology
Inhaling a Puff of Llama Antibodies to Relieve COVID
DEC 28, 2020
Inhaling a Puff of Llama Antibodies to Relieve COVID
Scientists at the National Institutes of Health have identified new antibody-based weapons in the fight against COVID-19 ...
JAN 03, 2021
Drug Discovery & Development
How Psychedelic Salvinorin A Works in the Brain
JAN 03, 2021
How Psychedelic Salvinorin A Works in the Brain
Despite increasing interest in hallucinogens, the effects of Salvinorin A, a drug used in Native Mexican rituals, have r ...
JAN 13, 2021
Drug Discovery & Development
Antibody Can Target Dengue Viral Proteins
JAN 13, 2021
Antibody Can Target Dengue Viral Proteins
Researchers have found an antibody that can stop the spread of the dengue virus—a mosquito-borne pathogen that inf ...
Loading Comments...